Abstract
Background: The lower respiratory tract infections remained the
deadliest communicable disease worldwide. The relationship between
cardiovascular diseases and viral infections is well known, namely
myocarditis. AH1N1 influenza pandemic showed an association with
developing acute cardiovascular disease, including ischemic events.
Besides, the new pandemic of SARS-CoV2 became a new challenge for
cardiovascular health. In early reports showed cardiac damage in
patients infected with SARS-CoV2. This study aimed to describe the
clinical characteristics with an emphasis on cardiovascular compromises
of COVID-19 patients. Moreover, to compare with outbreaks of influenza
AH1N1 to identify prognostic factors of severity. Methods: A
cross-sectional study, 72 subjects with a confirmed diagnosis of
COVID-19 was included, Subjects were evaluated in two groups; those
hospitalized and those who required Intensive Care Unite (ICU). The data
from different AH1N1 outbreaks were obtained from Velazquez et al.
Results: Thirty-four subjects were admitted to ICU. Subjects at ICU,
have greater levels of high sensible troponin, D dimer, creatinine, and
leukocytes, than hospitalized subjects. The lymphocytes count where
diminished in 85.29% of ICU subjects. SARS-CoV2 disease patients were
more than one-decade older than patients in the influenza outbreaks. In
SARS-CoV2 subjects the overweight and obesity proportion is half than in
the influenza outbreaks; there is a big proportion, more than 6 times,
of diabetes mellitus in SARS-CoV2 subjects. Conclusions: Viral
respiratory infection disease as SARS-CoV2 is a significant risk factor
for acute ischemic, functional, and structural cardiovascular
complications.